Abstract
Results from a cross-sectional study of Crimean-Congo haemorrhagic fever virus (CCHFV) in northern Tanzania demonstrated high seroprevalence in humans and ruminant livestock with high levels of spatial heterogeneity. CCHFV may represent an unrecognised human health risk in this region and drivers of exposure need further investigation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the Supporting Evidence Based Interventions project, University of Edinburgh (R83537) and the Zoonoses and Emerging Livestock Systems program (funded through BBSRC, DfID, ESRC, MRC, NERC and DSTL) (BB/L018926/1). EH was supported by the University of Glasgow, College of Medicine, Veterinary and Life Sciences Doctoral Training Programme.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Kilimanjaro Christian Medical Centre (KCMC), Moshi, Tanzania (832) gave ethical approval for this work Ethics committee of National Institute of Medical Research (NIMR), Tanzania (2028) gave ethical approval for this work Ethics Committee of the University of Glasgow Medical, Veterinary and Life Sciences (MVLS) (200140152) gave ethical approval for this work. Permission to carry out the study in Tanzania was provided by the Tanzania Commission for Science and Technology (2014-244-ER-2005-141). Written informed consent or assent for sample collection and questionnaire administration was collected from all participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors